Get the Stockscreener App
3.57
0.78%
0.00
Sophia Genetics Sa stock is traded at $3.57, with a volume of 26,891.
It is up +0.78% in the last 24 hours and up +18.55% over the past month.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
See More
Previous Close:
$3.57
Open:
$3.58
24h Volume:
26,891
Relative Volume:
0.52
Market Cap:
$237.19M
Revenue:
$64.49M
Net Income/Loss:
$-71.40M
P/E Ratio:
-3.2752
EPS:
-1.09
Net Cash Flow:
$-52.00M
1W Performance:
+2.80%
1M Performance:
+18.55%
6M Performance:
-1.43%
1Y Performance:
-17.86%
1-Day Range:
$3.56
$3.78
1-Week Range:
$3.275
$3.9276
52-Week Range:
$2.70
$7.37
Sophia Genetics Sa Stock (SOPH) Company Profile
Name
Sophia Genetics Sa
Sector
Industry
Phone
-
Address
-
Compare SOPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SOPH
Sophia Genetics Sa
|
3.595 | 237.19M | 64.49M | -71.40M | -52.00M | -1.09 |
|
VEEV
Veeva Systems Inc
|
237.21 | 38.87B | 2.66B | 665.91M | 1.08B | 4.05 |
|
SOLV
Solventum Corp
|
73.09 | 12.92B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
DOCS
Doximity Inc
|
80.09 | 10.88B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
68.12 | 10.23B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
112.42 | 9.71B | 1.15B | 96.70M | -161.99M | 1.09 |
Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-18-24 | Initiated | Craig Hallum | Buy |
| Aug-07-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-27-24 | Initiated | Guggenheim | Buy |
| Nov-29-23 | Initiated | RBC Capital Mkts | Outperform |
| Jul-05-23 | Resumed | JP Morgan | Overweight |
| Jan-03-23 | Initiated | BTIG Research | Buy |
| Nov-23-22 | Initiated | Credit Suisse | Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Aug-17-21 | Initiated | Cowen | Outperform |
| Aug-17-21 | Initiated | Credit Suisse | Outperform |
| Aug-17-21 | Initiated | JP Morgan | Overweight |
| Aug-17-21 | Initiated | Morgan Stanley | Overweight |
View All
Sophia Genetics Sa Stock (SOPH) Latest News
SOPHiA Genetics SA (SOPH) Stock: Analyzing the Market Value - The News Heater
Apartment Investment & Management Co (AIV) Stock: A Study of the Market Performance - The News Heater
Stock market today: Haoxi Health Technology -30.00%, Planet Image International -26.26% among biggest losers in early trading - Business Upturn
SOPHSOPHiA GENETICS SA Ordinary Shares Latest Stock News & Market Updates - StockTitan
SOPHiA GENETICS Launches Comprehensive MRD Tracking Capabilities -January 28, 2025 at 08:47 am EST - Marketscreener.com
SOPHiA GENETICS Launches Comprehensive MRD Tracking Capabilities – Company Announcement - Financial Times
SOPHiA GENETICS Launches Comprehensive MRD Tracking Capabilities - Barchart
Game-Changing Cancer Detection Tool Spots What Others Miss: New Breakthrough from SOPHiA GENETICS - StockTitan
Tempus AI Stock Before Q4 Earnings: To Buy Or Not To Buy? - Barchart
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Bioinformatics Market Analysis: Key Trends, Growth Drivers and Key Companies 2025 – 2032 - Newstrail
AI In Genomics Global Market Report 2024: Exponential Market - openPR
Short Interest in SOPHiA GENETICS SA (NASDAQ:SOPH) Decreases By 15.1% - MarketBeat
3 US Penny Stocks With Market Caps Under $200M - Simply Wall St
Shareholders Should Be Pleased With SOPHiA GENETICS SA's (NASDAQ:SOPH) Price - Simply Wall St
Genomic Biomarkers Market Report: Personalized Medicine - GlobeNewswire
Genomic Biomarkers Market Report: Personalized Medicine Powers 17.4% CAGR in Genomic Biomarkers Through 2028 - Yahoo Finance
The Zacks Analyst Blog Highlights Tempus AI, iRhythm Technologies and SOPHiA GENETICS - Yahoo Finance
Tempus AI Stock Surges 23% In 6 Months: Should You Snap It Up Now? - Barchart
Radiomics Market Top Companies StudyRadiomics.io - openPR
Principal Financial Group Inc. Buys 86,764 Shares of SOPHiA GENETICS SA (NASDAQ:SOPH) - Defense World
JPMorgan Chase & Co. Purchases 1,399,131 Shares of iShares 5-10 Year Investment Grade Corporate Bond ETF (NASDAQ:IGIB) - Defense World
Short Interest in SOPHiA GENETICS SA (NASDAQ:SOPH) Grows By 38.6% - MarketBeat
SOPHiA GENETICS (NASDAQ:SOPH) Coverage Initiated at Craig Hallum - Defense World
Guggenheim Initiates Coverage of SOPHiA GENETICS (SOPH) with Buy Recommendation - MSN
Growth Trends in Europe's Precision Medicine Software - GlobeNewswire
Growth Trends in Europe's Precision Medicine Software Market: Focus on Product Type, Application, End User, and CountryAnalysis and Forecast, 2024-2033 - GlobeNewswire
SOPHiA GENETICS (NASDAQ:SOPH) Now Covered by Analysts at Craig Hallum - MarketBeat
Craig-Hallum Initiates Coverage of SOPHiA GENETICS (SOPH) with Buy Recommendation - MSN
SOPHiA GENETICS's SWOT analysis: biopharma firm navigates headwinds, eyes growth - Investing.com Australia
SOPHiA GENETICS's SWOT analysis: biopharma firm navigates headwinds, eyes growth By Investing.com - Investing.com South Africa
SOPHiA GENETICS SA (NASDAQ:SOPH) Short Interest Update - MarketBeat
Precision Medicine Software Market to Witness Substantial Growth and New Opportunities from 2024 to 2031 As... - WhaTech
US Penny Stocks To Watch In December 2024 - Simply Wall St
Bioinformatics Market to Grow by USD 13.2 Billion (2024-2028), Lower Genetic Sequencing Costs Drive Revenue, Report Highlights AI's Role in TransformationTechnavio - The Malaysian Reserve
SOPHiA GENETICS Reports Third Quarter 2024 Results - GuruFocus.com
Principal Financial Group Inc. Acquires 86,764 Shares of SOPHiA GENETICS SA (NASDAQ:SOPH) - Defense World
SOPHiA GENETICS Launches MSK-IMPACT® powered with SOPHiA DDM™ at AMP 2024 – Company Announcement - Financial Times
SOPHiA GENETICS Launches Advanced Cancer Profiling Platform with 99.3% Accuracy - StockTitan
SOPHiA GENETICS's SWOT analysis: data-driven medicine stock faces headwinds - Investing.com India
SOPHiA GENETICS (NASDAQ:SOPH) vs. SpringWorks Therapeutics (NASDAQ:SWTX) Financial Review - Defense World
Earnings Release: Here's Why Analysts Cut Their SOPHiA GENETICS SA (NASDAQ:SOPH) Price Target To US$6.00 - Yahoo Finance
SOPHiA GENETICS SA (NASDAQ:SOPH) Q3 2024 Earnings Call Transcript - Insider Monkey
Earnings call: SOPHiA GENETICS reported a16% year-over-year increase in analysis volume - Investing.com
SOPHiA GENETICS Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance
Sophia Genetics SA (SOPH) Q3 2024 Earnings Call Highlights: Navigating Challenges with ... By GuruFocus - Investing.com Canada
SOPHiA GENETICS Q3 2024 Financial Highlights - TipRanks
SOPHiA GENETICS Promotes Ross Muken to President and Appoints George Cardoza as Chief Financial Officer - Marketscreener.com
3 Reasons Not to Give Up on Roku Stock - MSN
Vanguard Dethrones BlackRock As Second Largest ETF Manager: Here's How Their Funds With Exposure To S&P 500 Fared This Year - MSN
SOPHiA GENETICS Strengthens Leadership: Names New President, Appoints Industry Veteran CFO - StockTitan
Sophia Genetics Sa Stock (SOPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
7.39%
0.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):